Vrotsos Elena, Alexis John
Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL.
Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):26-9. doi: 10.1097/PAI.0000000000000146.
Microscopic evaluation of sentinel lymph nodes for metastatic melanoma relies, in part, on the use of immunohistochemical analysis to identify minute metastatic deposits that may be overlooked on routine microscopy. At present S100 protein is widely used in this role, in large part for its superior sensitivity; however, interpretation is hampered by the presence of benign S100 protein-positive cellular elements present in every lymph node, leading to reduced specificity and consequent difficulties in interpretation. In recent years, multiple melanocytic markers have emerged that promise superior sensitivity and specificity, including KBA.62 and SOX-10. SOX-10 shows a nuclear pattern of staining. In normal tissue it is expressed in Schwann cells, melanocytes, and myoepithelial cells of salivary, bronchial, and mammary glands. KBA.62 is also specific except for staining of endothelial cells and shows a membranous staining pattern. This study was undertaken to determine whether KBA.62 or SOX-10 could equal (or surpass) the sensitivity of S100 protein while offering superior specificity in the immunohistochemical evaluation of sentinel lymph nodes for metastatic melanoma.
In this study we performed immunohistochemical stains for S100 protein, Sox-10, and KBA.62 on 50 lymph nodes with proven metastatic melanoma.
SOX-10 detected all cases of metastatic melanoma (50 of 50 cases; 100%) compared with S100 protein (48 of 50 cases; 96%) and KBA.62 (37 of 50 cases; 74%). There was no "background" staining of normal cellular elements with SOX-10 or KBA.62. In contrast, S100 protein was expressed in scattered dendritic interdigitating reticulum cells in the paracortex of lymph nodes, showing cytoplasmic and nuclear positivity, sometimes posing significant difficulty in differentiating benign reticulum cells from single cell metastatic melanoma.
Our findings suggest that SOX-10 may be superior to S100 protein for identifying metastatic melanoma in a lymph node. KBA.62 was less sensitive than either marker, although more specific than S100 protein.
前哨淋巴结转移性黑色素瘤的显微镜评估部分依赖于免疫组化分析,以识别常规显微镜检查可能遗漏的微小转移灶。目前,S100蛋白因其卓越的敏感性而广泛用于此用途;然而,每个淋巴结中存在的良性S100蛋白阳性细胞成分会影响结果解读,导致特异性降低,进而造成解读困难。近年来,多种黑素细胞标志物相继出现,有望实现更高的敏感性和特异性,包括KBA.62和SOX-10。SOX-10呈核染色模式。在正常组织中,它表达于施万细胞、黑素细胞以及唾液腺、支气管和乳腺的肌上皮细胞。KBA.62也具有特异性,除了内皮细胞染色外,呈膜染色模式。本研究旨在确定在转移性黑色素瘤前哨淋巴结的免疫组化评估中,KBA.62或SOX-10能否在提供更高特异性的同时,与S100蛋白的敏感性相当(或更高)。
在本研究中,我们对50个已证实有转移性黑色素瘤的淋巴结进行了S100蛋白、Sox-10和KBA.62的免疫组化染色。
SOX-10检测到所有转移性黑色素瘤病例(50例中的50例;100%),而S100蛋白为(50例中的48例;96%),KBA.62为(50例中的37例;74%)。SOX-10或KBA.62对正常细胞成分均无“背景”染色。相比之下,S100蛋白在淋巴结副皮质中散在的树突状交错网状细胞中表达,呈细胞质和细胞核阳性,有时在区分良性网状细胞与单细胞转移性黑色素瘤时存在重大困难。
我们的研究结果表明,在识别淋巴结中的转移性黑色素瘤方面,SOX-10可能优于S100蛋白。KBA.62的敏感性低于这两种标志物,尽管其特异性高于S100蛋白。